• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

ADC Therapeutics SA Common Shares (NY:ADCT)

1.600 +0.100 (+6.67%)
Official Closing Price Updated: 4:10 PM EDT, Oct 22, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 823,704
Open 1.500
Bid (Size) 1.500 (300)
Ask (Size) 1.820 (1,500)
Prev. Close 1.500
Today's Range 1.479 - 1.620
52wk Range 0.7796 - 4.980
Shares Outstanding 76,721,543
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
ADC Therapeutics (ADCT) Q2 2026 Earnings Call Transcript ↗
August 20, 2026
FDA raised safety concerns about ZYNLONTA combination therapy in LOTIS-5 trial. 
Via The Motley Fool
Topics Earnings
News headline image
ADC Therapeutics Q2 Earnings Call Highlights ↗
August 13, 2026
ADC Therapeutics (NYSE:ADCT) reported second-quarter 2026 net product revenue of $18.6 million for ZYNLONTA, up from $18.1 million in the prior-year period, while executives said the treatment’s... 
Via MarketBeat
Topics Earnings

Performance

52-Week Range 67.9% below 52-week high
1.600
0.7852W Low 4.9852W High
1 Week
1.391W Low 1.561W High

ADC Therapeutics SA Common Shares (ADCT) traded between $0.78 and $4.98 over the past 52 weeks and last traded at $1.60, 67.9% below its 52-week high. Over the past week it ranged between $1.39 and $1.56.

Past 12 Months
+7.4%
+42.9%
+29.0%
-60.9%
-54.5%
-61.3%
1W +$0.11
1M +$0.48
3M +$0.36
6M -$2.49
YTD -$1.92
1Y -$2.53

ADCT was -61.3% over the past year, -60.9% over six months, -54.5% year to date, +7.4% in the last week.

12 Months vs Market
ADCT
-61.3%
DIA
+12.5%
SPY
+13.8%
QQQ
+15.2%
IWM
+12.0%

Over the past 12 months ADCT returned -61.3% versus DIA (Dow) +12.5%, SPY (S&P 500) +13.8%, QQQ (Nasdaq 100) +15.2% and IWM (Russell 2000) +12.0%.

Volume & Liquidity 0.54× 3-mo avg
Today 823,704 3-mo avg 1.5M
1W
1.0M
1M
1.7M
3M
1.5M
6M
1.7M
YTD
1.4M
1Y
1.4M

ADCT most recently traded 823,704 shares against a 3-month average daily volume of 1.5M.

More News

Read More
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT
June 23, 2026
From Pomerantz LLP
Via GlobeNewswire
ADC Therapeutics SA (NYSE:ADCT) Beats Q1 Estimates, But Market Reaction Remains Subdued ↗
May 04, 2026
Via Chartmill
ADC Therapeutics SA (NYSE:ADCT) Surges on Q4 2025 Earnings Beat and Pipeline Update ↗
March 10, 2026
Via Chartmill
Topics Earnings
News headline image
Earnings Scheduled For November 10, 2025 ↗
November 10, 2025
Via Benzinga
News headline image
Earnings Preview For ADC Therapeutics ↗
November 07, 2025
Via Benzinga
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of ADC Therapeutics SA – ADCT
June 16, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT
June 09, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
Why Is ADC Therapeutics Stock Falling On Friday? ↗
June 05, 2026
Via Benzinga
Which stocks are experiencing notable movement on Thursday? ↗
June 04, 2026
Via Chartmill
Top movers analysis in the middle of the day on 2026-06-04: top gainers and losers in today's session. ↗
June 04, 2026
Via Chartmill
Which stocks are gapping on Thursday? ↗
June 04, 2026
Via Chartmill
These stocks that are showing activity before the opening bell on Thursday. ↗
June 04, 2026
Via Chartmill
Which stocks are moving after the closing bell on Wednesday? ↗
June 03, 2026
Via Chartmill
News headline image
ADC Therapeutics (ADCT) Q4 2025 Earnings Call Transcript ↗
May 04, 2026
Via The Motley Fool
Topics Earnings
News headline image
ADCT Q1 2026 Earnings Call Transcript ↗
May 04, 2026
Via The Motley Fool
Topics Earnings
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT
January 20, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT
January 13, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT
January 06, 2026
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT
December 30, 2025
From Pomerantz LLP
Via GlobeNewswire
News headline image
These stocks are moving in today's session ↗
December 03, 2025
Via Chartmill
News headline image
Which stocks are gapping on Wednesday? ↗
December 03, 2025
Via Chartmill
News headline image
ADC Therapeutics (ADCT) Earnings Call Transcript ↗
November 10, 2025
Via The Motley Fool
Topics Earnings
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
October 02, 2025
Via Benzinga

Frequently Asked Questions

Is ADC Therapeutics SA Common Shares publicly traded?
Yes, ADC Therapeutics SA Common Shares is publicly traded.
What exchange does ADC Therapeutics SA Common Shares trade on?
ADC Therapeutics SA Common Shares trades on the New York Stock Exchange
What is the ticker symbol for ADC Therapeutics SA Common Shares?
The ticker symbol for ADC Therapeutics SA Common Shares is ADCT on the New York Stock Exchange
What is the current price of ADC Therapeutics SA Common Shares?
The current price of ADC Therapeutics SA Common Shares is 1.600
When was ADC Therapeutics SA Common Shares last traded?
The last trade of ADC Therapeutics SA Common Shares was at 10/22/26 04:10 PM ET
What is the market capitalization of ADC Therapeutics SA Common Shares?
The market capitalization of ADC Therapeutics SA Common Shares is 122.75M
How many shares of ADC Therapeutics SA Common Shares are outstanding?
ADC Therapeutics SA Common Shares has 123M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap